| bioMérieux
INDUSTRY’s Manual API®
Test Systems Obtain CE Marking
 HAZELWOOD,
MO - bioMérieux INDUSTRY has announced that their Manual
API Test Systems, the reference method for manual identification
to the species level for microorganisms, have obtained CE Marking
in accordance with the European Union (EU) Directive for In-Vitro
Diagnostic Devices. This European Union Directive is one of many
directives that are intended to eliminate non-tariff barriers
to trade and to assure that products flowing throughout the EU
comply with general safety and environmental norms. The CE Mark
reflects bioMérieux INDUSTRY’s commitment to providing
state-of-the-art products, while increasing safety and security
for their customers.
API offers a large and robust database, with test kits for identification
of
organisms ranging from Gram – to Gram + and yeast. The products
comprise strips
that generally contain 20 miniature biochemical tests. Currently,
there are 16
identification products covering most bacterial groups and over
550 different
species. API strips are economical to run and user-friendly. They
have a long shelf
life, enabling every laboratory to keep API on hand and ready
when needed. API
gives reproducible identification results, with extensive databases
and are standardized,
easy-to-use test systems.
For more information, please contact bioMérieux INDUSTRY
at 1.800.634.7656.
About bioMérieux INDUSTRY
bioMérieux INDUSTRY provides product solutions
to quality control and research microbiology laboratories. Applications
served include environmental monitoring, sterility testing, pathogen
screening, quality indicators, microbial identification, quality
control organisms, microbial limits and preservative effectiveness
testing.
About bioMérieux
A global leader in disease prevention and management, bioMérieux
provides assays, reagents and instrumentation for clinical microbiology,
coagulation, immunoassay, and nucleic acid diagnostics; and also
for product quality control in the agri-food, cosmetics and pharmaceutical
industries. Based in Marcy-l’Etoile, France, the company’s
U.S. headquarters is in Durham, North Carolina.
With sales of 950 million Euros in 2002, bioMérieux ranks
as the eighth largest
biological diagnostics company worldwide. Over 81% of its activity
takes place on an
international level. Investment in research and development represents
13% of sales.
bioMérieux, employs 5400 people throughout the world,
including 3200 in Europe and 1500 in the US. The group has 15
production sites distributed in France, the United States, Brazil,
Italy and the Netherlands, as well as a European logistics center
in France.
Already present in over 130 countries, with more than 110 distributors
and 32 subsidiaries, bioMérieux continues its international
development by strengthening its presence in Latin America and
Asia.
Return to bioMérieux News |
